Please Wait
Applying Filters...
menu
    • menu
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    Buntanetap

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,619,750Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Annovis Reports Biomarker Data Backing Buntanetap in Alzheimer
    Annovis Reports Biomarker Data Backing Buntanetap in Alzheimer

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3164035/0/en/Annovis-Announces-Novel-Biomarker-Data-in-Alzheimer-s-Patients-Supporting-Buntanetap-s-Potential-as-a-Disease-Modifying-Treatment.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share
    Annovis Highlights Pharmacokinetics of Novel Crystal Buntanetap
    Annovis Highlights Pharmacokinetics of Novel Crystal Buntanetap

    16 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/16/3150674/0/en/Annovis-Reports-Peer-Reviewed-Publication-Highlighting-Pharmacokinetics-of-Novel-Crystal-Buntanetap.html

    GLOBENEWSWIRE
    16 Sep 2025
    Share Share
    Buntanetap shows promise in early Parkinson's with mild dementia
    Buntanetap shows promise in early Parkinson's with mild dementia

    09 Apr 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/buntanetap-shows-promise-in-early-parkinsons-with-mild-dementia-globaldata/

    EXPRESSPHARMA
    09 Apr 2025
    Share Share
    Annovis Announces First Patients in Phase 3 Study for Alzheimer’s
    Annovis Announces First Patients in Phase 3 Study for Alzheimer’s

    05 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/05/3021101/0/en/Annovis-Announces-First-Patients-Entered-into-Pivotal-Phase-3-Study-of-Buntanetap-for-Early-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    05 Feb 2025
    Share Share
    Annovis Bio Gets US Patent For TBI Treatment With Buntanetap
    Annovis Bio Gets US Patent For TBI Treatment With Buntanetap

    24 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/24/2917931/0/en/Annovis-Bio-Secures-U-S-Patent-for-Treatment-of-Acute-Traumatic-Brain-Injury-with-Buntanetap.html

    GLOBENEWSWIRE
    24 Jul 2024
    Share Share
    Annovis Bio FDA-Approved To Use New Buntanetap Crystal Form
    Annovis Bio FDA-Approved To Use New Buntanetap Crystal Form

    16 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/16/2913695/0/en/Annovis-Bio-Receives-FDA-Approval-to-Transition-to-New-Crystal-Form-of-Buntanetap.html

    GLOBENEWSWIRE
    16 Jul 2024
    Share Share